Literature DB >> 4729899

Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function.

T W Wilson, W A Mahon, T Inaba, G E Johnson, D Kadar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4729899     DOI： 10.1002/cpt1973145815

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  12 in total

1.  Serum levels of gentamicin at peak and trough in neonates and infants.

Authors:  M Shahidullah; M Q Talukder; A K Chowdhury; S Ali; A Rashid
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

2.  Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics.

Authors:  A Mosegaard; P G Welling; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

Review 3.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

4.  The renal handling of polybasic drugs. 1. Gentamicin and aprotinin in intact animals.

Authors:  M Just; G Erdmann; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

5.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

Review 6.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

7.  Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).

Authors:  Julie M Varghese; Jason A Roberts; Steven C Wallis; Robert J Boots; Helen Healy; Robert G Fassett; Jeffrey Lipman; Dwarakanathan Ranganathan
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

Review 8.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

9.  Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.

Authors:  Michael J Satlin; Christine J Kubin; Jill S Blumenthal; Andrew B Cohen; E Yoko Furuya; Stephen J Wilson; Stephen G Jenkins; David P Calfee
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

10.  DNA copy-number measurement of genome replication dynamics by high-throughput sequencing: the sort-seq, sync-seq and MFA-seq family.

Authors:  Dzmitry G Batrakou; Carolin A Müller; Rosemary H C Wilson; Conrad A Nieduszynski
Journal:  Nat Protoc       Date:  2020-02-12       Impact factor: 13.491
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.